Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-40.43	21.44	35.99
Graham Fair Price	226.85	8.33	2.55
PEG	-99.24	-0.01	1.58
Price/Book	-22.99	2.93	3.80
Price/Cash Flow	571.09	122.22	18.21
Prices/Earnings	-92.17	13.41	-171.31
Price/Sales	-15.00	4.12	4.85
Price/FCF	571.09	122.22	18.21
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	5.51	0.50	0.48
Operating Margin	13.35	0.26	0.23
ROA	959.11	< 0.005	< 0.005
ROE	< 0.005	0.05	883.43
ROIC	< 0.005	0.03	197.21
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.03	-0.02	-51.80
Dividends QOQ	< 0.005	-1.00	43003.45
EBIT QOQ	0.07	0.07	-1.15
EPS QOQ	-1.09	11.25	936.76
FCF QOQ	0.60	-0.88	46.47
Revenue QOQ	0.06	-0.06	-8.65
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	48.27	54.51	12.92
Days Sales Outstanding (DSO)	76.86	60.98	-20.65
Inventory Turnover	1.86	1.65	-11.44
Debt/Capitalization	0.80	0.79	-2.20
Quick Ratio	0.91	0.50	-44.88
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	7.22	7.52	4.23
Cash	2.86	2.48	-13.29
Capex	-0.49	-0.42	14.29
Free Cash Flow	1.51	0.18	-88.04
Revenue	5.65	5.34	-5.58
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.25	0.80	-36.36
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	17.78	11.66	-34.41
Naive Interpretation	Member

06 - Financial Health · Bad

Rating